New cancer clinical trial: Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer

Published on: February 07, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share